The biggest stories of the day delivered to your inbox.

IBM is busy applying its Watson AI to as many health arenas as possible and it looks like cancer genomic sequencing could be its next big market. In a new proof-of-concept study testing a beta ...

IBM has unveiled new data for its Watson AI which shows the software to be in agreement with doctor's recommendations up to 96% of the time. Unveiled at this year's American Society of Clinical ...